Sign in

CIK 0001655759

  • Accelerated filer

ARVINAS, INC.

Sign in to watch
Ticker
ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472566120
Phone
+1 203-535-1456
Business address
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,475
in 1 filing, $1K under 10b5-1 plans

Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loomis David K −$1K VP, Chief Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-16 Houston John G President and CEO Sale −600 $80.25 $48K 816,200
2021-02-16 Houston John G President and CEO Exercise or conversion · Stock Option (right to buy) −44,000 88,880
2021-02-16 Cassidy Sean A Chief Financial Officer Exercise or conversion +6,815 $16.00 $109K 161,599
2021-02-16 Cassidy Sean A Chief Financial Officer Exercise or conversion +35,144 $16.00 $562K 196,743
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −8,158 $77.60 $633K 188,585
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −19,303 $78.61 $1.5M 169,282
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −3,958 $79.32 $314K 165,324
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −396 $80.28 $32K 164,928
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −2,793 $77.62 $217K 162,135
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −6,160 $78.65 $484K 155,975
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −1,161 $79.42 $92K 154,814
2021-02-16 Cassidy Sean A Chief Financial Officer Sale −30 $80.43 $2K 154,784
2021-02-16 Cassidy Sean A Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −6,815 0
2021-02-16 Cassidy Sean A Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −35,144 46,262
2021-02-16 Peck Ronald Chief Medical Officer Exercise or conversion +20,000 $26.58 $532K 22,754
2021-02-16 Peck Ronald Chief Medical Officer Sale −20,000 $77.35 $1.5M 2,754
2021-02-16 Peck Ronald Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −20,000 52,184
2020-12-31 Houston John G President and CEO Grant or award +310 $29.02 $9K 818,248
2020-12-18 Ratcliffe Liam Director Purchase +142,857 $70.00 $10.0M 822,857
2020-11-09 Kennedy Edward Moore Jr. Director Purchase +8,333 $23.99 $200K 42,718

Page 21 of 32 · 628 trades